Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIFK pseudogene 3 (NIFKP3)
- Target
- NIFKP3
- Molecular classification
- Other (Pseudogene)
01
Overview
NIFK pseudogene 3 (NIFKP3) is annotated as a pseudogene, meaning it is a nonfunctional DNA sequence that resembles a functional gene (in this case, homologous to NIFK, which interacts with the FHA domain of MKI67). Pseudogenes like NIFKP3 are generally not transcribed or translated into functional proteins and are not considered therapeutic targets, though some pseudogenes in other contexts can contribute regulatory RNAs or serve as evolutionarily relevant markers. There are currently no known biological functions, disease associations, drug interactions, or biomarkers related to NIFKP3[1][2].
- Other names
- MKI67IPP3MKI67 (FHA domain) interacting nucleolar phosphoprotein pseudogene 3nucleolar protein interacting with the FHA domain of MKI67 pseudogene 3NIFKP3
02
Biological functions
None (as a pseudogene, NIFKP3 does not encode a functional protein and thus has no established biological function)
03
Disease associations
Other (no known direct disease role; most pseudogenes are not directly implicated in disease, although exceptions exist for other pseudogenes)
Beyond the preview
Go deeper on NIFK pseudogene 3 (NIFKP3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NIFK pseudogene 3 (NIFKP3).